Since the launch of our post-effect middleware YEBIS in 2006, Silicon Studio has continuously invested in research and ...

Discover the tricks of the trade of cinematographer Andrew Rodger as he mixes vintage lenses with digital video cameras ...

Three years after Daiichi Sankyo's FLR3 inhibitor quizartinib was rejected by the FDA, the drugmaker has reported the results of a new phase 3 trial that is key to getting the drug to the US ...